Literature DB >> 11602506

Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association.

A C Schoolwerth, D A Sica, B J Ballermann, C S Wilcox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11602506     DOI： 10.1161/hc4101.096153

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  87 in total

1.  Bilateral renovascular disease causing cardiorenal failure.

Authors:  Alison Brammah; Sue Robertson; Graeme Tait; Chris Isles
Journal:  BMJ       Date:  2003-03-01

Review 2.  The evolution of renin-angiotensin blockade: angiotensin-converting enzyme inhibitors as the starting point.

Authors:  Domenic A Sica
Journal:  Curr Hypertens Rep       Date:  2010-04       Impact factor: 5.369

Review 3.  Cardiorenal syndrome: still not a defined entity.

Authors:  Carlo Longhini; Christian Molino; Fabio Fabbian
Journal:  Clin Exp Nephrol       Date:  2010-02-20       Impact factor: 2.801

4.  Angiotensin-converting enzyme inhibitor treatment and the development of urinary tract infections: a prescription sequence symmetry analysis.

Authors:  Koen B Pouwels; Sipke T Visser; H Jens Bos; Eelko Hak
Journal:  Drug Saf       Date:  2013-11       Impact factor: 5.606

5.  Managing drugs and devices in patients with permanent ventricular assist devices.

Authors:  Martin Cadeiras; Manuel von Bayern; Mario C Deng
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

6.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

7.  Angiotensin-converting enzyme inhibitors predict acute kidney injury during chemoradiation for head and neck cancer.

Authors:  Michael T Spiotto; Hongyuan Cao; Loren Mell; F Gary Toback
Journal:  Anticancer Drugs       Date:  2015-03       Impact factor: 2.248

8.  Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery.

Authors:  Pradeep Arora; Srini Rajagopalam; Rajiv Ranjan; Hari Kolli; Manpreet Singh; Rocco Venuto; James Lohr
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 8.237

9.  Renal handling of angiotensin receptor blockers: clinical relevance.

Authors:  Domenic A Sica
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

10.  Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).

Authors:  Yuko Shima; Koichi Nakanishi; Mayumi Sako; Mari Saito-Oba; Yuko Hamasaki; Hiroshi Hataya; Masataka Honda; Koichi Kamei; Kenji Ishikura; Shuichi Ito; Hiroshi Kaito; Ryojiro Tanaka; Kandai Nozu; Hidefumi Nakamura; Yasuo Ohashi; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2018-10-03       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.